, Singapore
714 views
From Deloitte

IPO market rebounds to $2.54b in 2025, driven by ‘blockbuster’ REITs

Deloitte highlights two secondary listings, regulatory reforms.

Singapore led Southeast Asia’s initial public offering (IPO) market by proceeds, as 13 IPOs raised $2.54b (US$2.0b) with a market capitalisation of $7.87b (US$6.2b) in 2025, driven by a stronger pipeline of Mainboard listings and two notable secondary listings.

The city-state’s previous highest IPO record within five years was in 2021, when it accounted for about $1.52b (US$1.2b) in proceeds and $3.05b (US$2.4b) in market capitalisation from eight IPOs, a Deloitte report said.

The market had a downward trend in proceeds starting in 2022, when it raised $543.56m (US$428m) in that year, whilst $44.45m (US$35m) in 2023, and $43.18m (US$34m) in 2024.

Market capitalisation for 2022 crashed to $798.83m (US$629m), whilst it further dipped to $252.73m (US$199m) in 2023, and had a slight rebound to $347.98m (US$274m) in 2024.

The report also showed that there were 11 IPOs in 2022, six in 2023, and four in 2024.

The real estate sector led the industry breakdown, raising $1.905b (US$1.5b) from four IPOs, which is 76% of Singapore’s total funds raised.

The sector is followed by the Life Sciences & Health Care sector with $508.00m (US$400m) from one IPO, and Technology, Media & Telecommunication with $60.96m (US$48m) from one IPO.

Other sectors include Consumers with $34.29m (US$27m) from five IPOs, Energy & Resources with $13.97m (US$11m) from one IPO, and Industrial Products with $6.35m (US$5m) from one IPO.

The Deloitte report also cited two “blockbuster” listings—namely NTT DC REIT and Centurion Accommodation REIT—which raised more than $635.00m (US$500m) each, accounting for 70% of Singapore’s total funds raised.

It also noted two secondary listings—China Medical Systems and Avepoint, Inc.—whilst cross-border listings include those from NASDAQ and Hong Kong Exchange Listings.

The Monetary Authority of Singapore (MAS) and Singapore Exchange (SGX) issued reforms for a disclosure-based regime to enhance market attractiveness.

SGX also lowered the profit test threshold for Mainboard admission from $30m to $10m.

MAS also plans to enhance the appeal of dual listings in Singapore and on NASDAQ by providing a seamless pathway for companies seeking such.

The city-state’s gross domestic product is also poised for 1.4% growth, according to the report.

US$1 = SG$1.27

Follow the link for more news on

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

If you've been wondering whether SBR could work for your company — yes, probably.

A lot of the companies we partner with started as readers. They'd been following our coverage for a while, saw their own customers and competitors in it, and eventually asked the obvious question: could we do something with you? The answer is usually yes. The shape of it depends on what you're trying to do.


The options are broader than most people assume — thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. Some partners use one channel; most use a mix. We figure out the right combination by starting with your brief, not with our rate card.


So if the question has been on your mind, here's the easy way to ask it.

We'll tell you honestly whether we can help, and how. It's a better use of everyone's time.